top of page
Interesting discussions with Visionaries, Entrepreneurs, CEOs, and Smart Business people!
Neuronix develops new methods for modifying the course of treatment for Alzheimer s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients.
Eyal Baror brings over a decade of experience in R&D and in executive-level positions in several medical device companies. A graduate of the prestigious Israel Defense Force’s Talpiot program, he holds a B.Sc. in Physics (cum-laude) from the Hebrew University of Jerusalem, and a M.Sc. in Physics (summa cum laude) from the Tel-Aviv University
bottom of page